Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region–anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 27,115 followers.

Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region-anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib https://t.co/U61Y8ilbe8

22 Oct 2022

Reply Repost Favourite

Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region-anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib #lymphoma #lymsm https://t.co/SntAQ7T2AX

21 Oct 2022

Reply Repost Favourite

Case report: Novel <em>junctional sarcoplasmic reticulum protein 1</em> intergenic region<em>-anaplastic lymphoma kinase</em> fusion in a patient with lung adenocarcinoma responds to alectinib #lymphoma #lymsm https://t.co/zZ3TV4wck

21 Oct 2022

Reply Repost Favourite

Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region–anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib: Novel anaplastic lymphoma kinase (ALK) fusions are… #oncology https://t.co/PdqU

04 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.